144 related articles for article (PubMed ID: 20875340)
21. A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy.
Stoff-Khalili MA; Rivera AA; Glasgow JN; Le LP; Stoff A; Everts M; Tsuruta Y; Kawakami Y; Bauerschmitz GJ; Mathis JM; Pereboeva L; Seigal GP; Dall P; Curiel DT
Gene Ther; 2005 Dec; 12(23):1696-706. PubMed ID: 16034451
[TBL] [Abstract][Full Text] [Related]
22. Strategies for enhancing viral-based gene therapy using ionizing radiation.
Chmura SJ; Advani SJ; Kufe DW; Weichselbaum RR
Radiat Oncol Investig; 1999; 7(5):261-9. PubMed ID: 10580895
[TBL] [Abstract][Full Text] [Related]
23. Telomerase-specific suicide gene therapy vectors expressing bacterial nitroreductase sensitize human cancer cells to the pro-drug CB1954.
Plumb JA; Bilsland A; Kakani R; Zhao J; Glasspool RM; Knox RJ; Evans TR; Keith WN
Oncogene; 2001 Nov; 20(53):7797-803. PubMed ID: 11753658
[TBL] [Abstract][Full Text] [Related]
24. Targeting metastatic cancer from the inside: a new generation of targeted gene delivery vectors enables personalized cancer vaccination in situ.
Gordon EM; Levy JP; Reed RA; Petchpud WN; Liu L; Wendler CB; Hall FL
Int J Oncol; 2008 Oct; 33(4):665-75. PubMed ID: 18813779
[TBL] [Abstract][Full Text] [Related]
25. Bacteria in gene therapy: bactofection versus alternative gene therapy.
Pálffy R; Gardlík R; Hodosy J; Behuliak M; Resko P; Radvánský J; Celec P
Gene Ther; 2006 Jan; 13(2):101-5. PubMed ID: 16163379
[TBL] [Abstract][Full Text] [Related]
26. Live attenuated bacteria as vectors to deliver plasmid DNA vaccines.
Dietrich G; Spreng S; Favre D; Viret JF; Guzman CA
Curr Opin Mol Ther; 2003 Feb; 5(1):10-9. PubMed ID: 12669465
[TBL] [Abstract][Full Text] [Related]
27. Double-copy bicistronic retroviral vector platform for gene therapy and tissue engineering: application to melanoma vaccine development.
Wiznerowicz M; Fong AZ; Mackiewicz A; Hawley RG
Gene Ther; 1997 Oct; 4(10):1061-8. PubMed ID: 9415312
[TBL] [Abstract][Full Text] [Related]
28. The genus Bifidobacterium for cancer gene therapy.
Fujimori M; Amano J; Taniguchi S
Curr Opin Drug Discov Devel; 2002 Mar; 5(2):200-3. PubMed ID: 11926126
[TBL] [Abstract][Full Text] [Related]
29. Cancer gene-therapy: clinical trials.
Palmer DH; Young LS; Mautner V
Trends Biotechnol; 2006 Feb; 24(2):76-82. PubMed ID: 16380178
[TBL] [Abstract][Full Text] [Related]
30. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
O'Malley BW; Li D; McQuone SJ; Ralston R
Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
[TBL] [Abstract][Full Text] [Related]
31. Gene therapy clinical trials worldwide 1989-2004-an overview.
Edelstein ML; Abedi MR; Wixon J; Edelstein RM
J Gene Med; 2004 Jun; 6(6):597-602. PubMed ID: 15170730
[TBL] [Abstract][Full Text] [Related]
32. Bacterial vectors for imaging and cancer gene therapy: a review.
Cronin M; Stanton RM; Francis KP; Tangney M
Cancer Gene Ther; 2012 Nov; 19(11):731-40. PubMed ID: 22996740
[TBL] [Abstract][Full Text] [Related]
33. Pathotropic nanoparticles for cancer gene therapy Rexin-G IV: three-year clinical experience.
Gordon EM; Lopez FF; Cornelio GH; Lorenzo CC; Levy JP; Reed RA; Liu L; Bruckner HW; Hall FL
Int J Oncol; 2006 Nov; 29(5):1053-64. PubMed ID: 17016635
[TBL] [Abstract][Full Text] [Related]
34. Noninfectious gene transfer and expression systems for cancer gene therapy.
Cooper MJ
Semin Oncol; 1996 Feb; 23(1):172-87. PubMed ID: 8607027
[TBL] [Abstract][Full Text] [Related]
35. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
[TBL] [Abstract][Full Text] [Related]
36. Le morte du tumour: histological features of tumor destruction in chemo-resistant cancers following intravenous infusions of pathotropic nanoparticles bearing therapeutic genes.
Gordon EM; Chan MT; Geraldino N; Lopez FF; Cornelio GH; Lorenzo CC; Levy JP; Reed RA; Liu L; Hall FL
Int J Oncol; 2007 Jun; 30(6):1297-307. PubMed ID: 17487349
[TBL] [Abstract][Full Text] [Related]
37. Adenovirus-mediated gene transfer to orthotopic hepatocellular carcinomas in athymic nude mice.
Yoon SK; Armentano D; Wands JR; Mohr L
Cancer Gene Ther; 2001 Aug; 8(8):573-9. PubMed ID: 11571535
[TBL] [Abstract][Full Text] [Related]
38. Retroviral vectors for gene therapy of AIDS and cancer.
Chang LJ; He J
Curr Opin Mol Ther; 2001 Oct; 3(5):468-75. PubMed ID: 11699891
[TBL] [Abstract][Full Text] [Related]
39. Clinical experience with adenovirus in cancer therapy.
Palmer DH; Mautner V; Kerr DJ
Curr Opin Mol Ther; 2002 Oct; 4(5):423-34. PubMed ID: 12435043
[TBL] [Abstract][Full Text] [Related]
40. Macrophages in gene therapy: cellular delivery vehicles and in vivo targets.
Burke B; Sumner S; Maitland N; Lewis CE
J Leukoc Biol; 2002 Sep; 72(3):417-28. PubMed ID: 12223508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]